The disclosure relates to the field of medical devices. More particularly, the disclosure relates to catheters and methods of using catheters.
Balloon catheters are widely used in the medical arts in a variety of procedures. Typically, balloon catheters are advanced within a lumen defined by a body vessel until a portion of the catheter, such as the balloon, reaches an intended point of treatment within the body vessel. The balloon is then inflated to affect a particular treatment, such as dilation, stent deployment, or another treatment.
In some situations, it may be desirable to provide a treatment effect at a location outside of a body vessel, such as the interstitial space surrounding a particular vessel. Unfortunately, while the medical device arts provide several examples of catheters adapted to provide a treatment effect at a point of treatment within a body vessel, there are few examples of catheters suitable for affecting treatment at a location outside of a body vessel.
A need remains, therefore, for new catheters and methods of using catheters.
Several example catheters are described and illustrated herein. One example catheter comprises an elongate shaft having a proximal end, a distal end, a main body extending between the proximal end and the distal end, and a longitudinal axis, the main body defining an inflation lumen; a balloon disposed on the distal end of the elongate shaft, the balloon having an external surface, a proximal balloon neck and a distal balloon neck, the balloon defining an interior chamber in fluid communication with the inflation lumen and adapted to move from an uninflated configuration to an inflated configuration as fluid moves from the inflation lumen into the interior chamber; a guide disposed on the external surface of the balloon between the proximal balloon neck and the distal balloon neck with respect to the longitudinal axis of the elongate tubular member; and an engaging member having an engaging member proximal end and an engaging member distal end, the engaging member distal end releasably secured by the guide such that the guide maintains the engaging member distal end adjacent the outer surface of the balloon when the balloon is in an uninflated configuration but releases the engaging member distal end as the balloon moves from an uninflated configuration to an inflated configuration.
Another example catheter comprises an elongate shaft having a proximal end, a distal end, a main body extending between the proximal end and the distal end, and a longitudinal axis, the main body defining an inflation lumen; a balloon disposed on the distal end of the elongate shaft, the balloon having an external surface, a proximal balloon neck, a distal balloon neck, and an intermediate portion extending between the proximal balloon neck and the distal balloon neck, the balloon defining an interior chamber in fluid communication with the inflation lumen and adapted to move from an uninflated configuration to an inflated configuration as fluid moves from the inflation lumen into the interior chamber; a guide disposed on the proximal balloon neck and extending into the intermediate portion of the balloon; and an engaging member having an engaging member proximal end and an engaging member distal end, the engaging member distal end releasably secured by the guide such that the guide maintains the engaging member distal end adjacent the outer surface of the balloon when the balloon is in an uninflated configuration but releases the engaging member distal end as the balloon moves from an uninflated configuration to an inflated configuration.
Another example catheter comprises an elongate shaft having a proximal end, a distal end, a main body extending between the proximal end and the distal end, and a longitudinal axis, the main body defining an inflation lumen; a balloon disposed on the distal end of the elongate shaft, the balloon having an external surface, a proximal balloon neck, a distal balloon neck, and an intermediate portion extending between the proximal balloon neck and the distal balloon neck, the balloon defining an interior chamber in fluid communication with the inflation lumen and adapted to move from an uninflated configuration to an inflated configuration as fluid moves from the inflation lumen into the interior chamber; a guide disposed on the proximal balloon neck and extending into the intermediate portion of the balloon, the guide defining a guide passageway; and an engaging member comprising a cannula defining an engaging member passageway, the engaging member having an engaging member proximal end, an engaging member distal end defining a cutting edge, and a portion disposed within the guide passageway.
Several example methods of using a catheter are described and illustrated herein. One example method of using a catheter comprises advancing a catheter through a body vessel to a first point of treatment; inflating the balloon of the catheter to a degree that places the distal end of the engaging member of the catheter in contact with the interior surface of the body vessel but that still allows axial movement of the catheter within the body vessel; distally advancing the catheter within the body vessel to a second point of treatment such that the distal end of the engaging member of the catheter punctures the vessel wall; and introducing an agent through the engaging member of the catheter and into the interstitial space adjacent the body vessel.
Another example method of using a catheter comprises advancing a catheter according to an example through a body vessel to a point of treatment; inflating the balloon of the catheter so that the distal end of the engaging member of the catheter punctures the vessel wall; and introducing an agent through the engaging member of the catheter and into the interstitial space adjacent the body vessel.
Additional understanding of the encompassed catheters and methods of using a catheter can be obtained by review the detailed description of selected examples, below, with reference to the appended drawings.
The following detailed description and the appended drawings describe and illustrate various examples. The description and illustration of these examples are provided to enable one skilled in the art to make and use a catheter. They are not intended to limit the scope of the claims in any manner.
As used herein, the term “engage” and grammatically related terms means to make contact with a structure.
As used herein, the term “puncture” means to create an opening in a structure. The term includes the creation of a hole that extends through the structure, but does not require it.
As used herein, the term “exemplary” means “an example of.” The term does not refer to an ideal or preferred example.
As used herein, the term “body vessel” refers to any passage within the body of an animal. The term includes elongate passages, arteries and veins, and cavities, such as sinus cavities.
The terms “score,” “scoring,” “cut,” and “cutting” refer to the making of disruptions in the surface of a tissue or a portion of a tissue, such as an inner wall of a body vessel, unless the context clearly dictates otherwise.
The term “agent” refers to a fluid or other composition of matter that can be introduced into a body via delivery through a component of a catheter. The term includes known medicaments, later-developed medicaments, and any other fluid or composition of matter of which introduction into a body is desired.
Each of
The catheter 10 includes an elongate shaft 12 extending between a proximal portion 14 that includes proximal end 16 and a distal portion 18 that includes distal end 20. A balloon 22 is attached to the distal portion 18 of the elongate shaft 12 at a proximal junction 24 and a distal junction 26. The balloon 22 defines an interior chamber 28 and has uninflated and inflated configurations.
The elongate shaft 12 defines an inflation lumen 30 that extends between an inflation port 32 and an opening 34 positioned on the distal portion 18 of the elongate shaft 12 and within the interior chamber 28 of the balloon 22. As such, the interior chamber 28 of the balloon 22 is in fluid communication with the inflation lumen 30 such that passage of a fluid through the inflation lumen 30, such as saline or another fluid, and into the interior chamber 28 of the balloon 22 causes the balloon 22 to move from an uninflated configuration to an inflated configuration. In reverse, withdrawal of fluid from the interior chamber 28 of the balloon and into the inflation lumen 30 causes the balloon 22 to move from an inflated configuration to an uninflated configuration. Fluid can be passed into the inflation lumen 30, and ultimately into and/or out of the interior chamber 28 of the balloon 22, from a storage vessel in fluid communication with the inflation lumen 30, such as a syringe or other suitable storage vessel operably connected to the inflation port 32.
The elongate shaft 12 also defines a wireguide lumen 36 that extends along a length of the elongate shaft 12 and terminates at a distal opening 38 defined by the distal end 20 of the elongate shaft 12. In use, the catheter 10 can be passed over a wireguide, such as a wireguide that has been previously placed in a body vessel, such that the wireguide is slidably disposed in the wireguide lumen 36. This enables the catheter 10 to be moved along the wireguide in accordance with conventional techniques. The wireguide lumen 36 can extend along any suitable length of the elongate shaft 12, including the entire length and a portion of the entire length. In the illustrated example, the wireguide lumen 36 extends along the entire length of the elongate shaft 12. This configuration makes the catheter 10 suitable for use as an over-the-wire device. In other examples, the wireguide lumen extends along only a portion of the entire length of the elongate shaft. This configuration makes these catheters suitable for use as a rapid exchange device. A skilled artisan will be able to select an appropriate configuration for a wireguide lumen in a catheter according to a particular example based on several considerations, including a desired overall working length of the catheter and the nature of the procedures and facilities within which the catheter is intended to be used.
The balloon 22 has an axial length 40 extending along the longitudinal axis of the elongate shaft 22. The balloon 22 defines a proximal balloon neck 42 and a distal balloon neck 44. An intermediate portion 46 is disposed between the proximal balloon neck 42 and distal balloon neck 44. The intermediate portion 46 extends from an intermediate portion proximal end 48 to an intermediate portion distal end 50. The proximal balloon neck 42 extends distally from junction 24 to intermediate portion proximal end 48 and has axial length 52. Similarly, the distal balloon neck 44 extends proximally from junction 26 to intermediate portion distal end 50 and has axial length 54. The intermediate portion 46 has axial length 56, also referred to as the “working length” of the balloon 22. The balloon 22 is adapted to achieve its maximum outer diameter along the working length 56 when in an inflated configuration.
Junctions 24, 26 can comprise any suitable attachment between members, and skilled artisans will be able to select appropriate attachments for a catheter according to a particular example based on various considerations, including the nature of the materials used in the elongate shaft and the balloon of the particular catheter. Examples of suitable attachments include attachments formed by heat fusion techniques and/or procedures, adhesive attachments, mechanical connections, and any other suitable attachments between members. No matter the type or form of attachment used, the junctions 24, 26 should sufficiently seal the proximal balloon neck 42 and the distal balloon neck 44 to the elongate shaft 12 so that fluid within the interior chamber 28 of the balloon 22 cannot pass through either junction 24, 26 as the balloon 22 is being moved from an uninflated configuration to an inflated configuration or from an inflated configuration to an uninflated configuration.
The balloon 22 has an outer surface 58 that defines a guide 60. The guide 60 is a structure adapted to releasably secure a distal end 84 of an engaging member 80 such that the guide 60 maintains the distal end 84 of the engaging member 80 in contact with the outer surface 58 of the balloon 22 when the balloon 22 is in an uninflated configuration but releases the distal end 84 of the engaging member 80 from contact with the outer surface 58 of the balloon 22 as the balloon moves from an uninflated configuration to an inflated configuration. The guide 60 can comprise any suitable structure defined by the outer surface 58 of the balloon 22 that is capable of releasably securing the distal end 84 of the engaging member 80 in this manner. In the illustrated example, as best illustrated in
While the guide 60 in the illustrated example comprises an undulating groove 62, the outer surface 58 of the balloon 22 can define any suitable structure as the guide 60. A skilled artisan will be able to select an appropriate structure for the guide in a catheter according to a particular example based on various considerations, including a desired ease with which the groove should release the distal end 84 of the engaging member 80 as the balloon 22 moves from an uninflated configuration to an inflated configuration. Examples of other suitable structures for the guide 60 include a groove having a substantially uniform width, a channel extending along a linear path on the outer surface 58 of the balloon 22, and a channel extending along a non-linear path on the outer surface 58 of the balloon 22, such as along a curvilinear path. Furthermore, a guide in a catheter according to a particular example can comprise a separate structure that is attached to the outer surface of the balloon, such as by an adhesive or other suitable attachment.
The guide 60 can extend along the outer surface 58 of the balloon for any suitable length. In the illustrated example, the guide 60 extends along the entire axial length 52 of the proximal balloon neck 42 and along a portion of the axial length 56 of the intermediate portion 46 of the balloon 22. Other suitable configurations include, but are not limited to, a guide that extends along only a portion of the axial length 52 of the proximal balloon neck 42, a guide that extends along only the entire axial length 52 of the proximal balloon neck 42, a guide that extends along a portion of the axial length 52 of the proximal balloon neck 42 and along a portion of the axial length 56 of the intermediate portion 46 of the balloon 22, and a guide that extends along the entire axial length 52 of the proximal balloon neck 42 and along the entire axial length 56 of the intermediate portion 46 of the balloon 22. A skilled artisan will be able to select a suitable configuration for the guide in a catheter according to a particular example based on various considerations, including the working length of the balloon for the particular catheter and the nature of the vessel within which the particular catheter is intended to be used. For examples in which the guide extends along a portion of the axial length of the intermediate portion of the balloon, any suitable portion of the axial length of the intermediate portion of the balloon can be used. Examples of suitable portions include a portion that is between 10% and 90% of the axial length of the intermediate portion, a portion that is between about 10% and about 90% of the axial length of the intermediate portion, a portion that is between 15% and 80% of the axial length of the intermediate portion, a portion that is between about 15% and about 80% of the axial length of the intermediate portion, a portion that is between 20% and 70% of the axial length of the intermediate portion, a portion that is between about 20% and about 70% of the axial length of the intermediate portion, a portion that is between 25% and 60% of the axial length of the intermediate portion, a portion that is between about 25% and about 60% of the axial length of the intermediate portion, a portion that is between 30% and 50% of the axial length of the intermediate portion, and a portion that is between about 30% and about 50% of the axial length of the intermediate portion.
Engaging member 80 is an elongate member having a proximal end 82 and a distal end 84. As described above, the distal end 84 is disposed in the guide 60 on the outer surface 58 of the balloon 22 when the balloon 22 is in an uninflated configuration.
The engaging member 80 can comprise any suitable structure that can be releasably secured by the guide 60 as described above. In the illustrated example, the engaging member 80 is an elongate cannula that defines an inner passageway 86 and a distal tip 88. The inner passageway 86 extends between a proximal opening 90 defined by the proximal end 82 and a distal opening 92 defined by the distal end 84. As such, a fluid can be introduced into the inner passageway 86 via the proximal opening 90 and forced to exit the inner passageway 86 via the distal opening 92. This makes the engaging member 80 suitable for delivery of a fluid, such as an agent 94 contained within an attached syringe 96 or other suitable storage container. A skilled artisan will be able to select an appropriate structure for the engaging member of a catheter according to a particular example based on various considerations, including an intended use of the particular catheter. For example, if the particular catheter is intended to be used for puncturing a vessel wall from a position within a lumen defined by the vessel and delivering an agent to the interstitial space surrounding the lumen, a cannula structure like that in the illustrated example will be suitable. If, however, puncture and/or delivery of an agent is not desired, an elongate rod structure lacking an inner passageway and including a rounded distal end is suitable. No matter the structure chosen for the engaging member of a catheter according to a particular example, the engaging member can have any suitable length, including a length that is longer than the length of the elongate shaft 12, a length that is the same as the length of the elongate shaft 12, a length that is substantially the same as the length of the elongate shaft 12, and a length that is less than the length of the elongate shaft 12.
It is noted that the engaging member 80 can be axially fixed in position relative to the elongate shaft 12 or can be axially movable relative to the elongate shaft 12. For example, in the example illustrated in
Also, it is noted that, while in the example illustrated in
The catheter 10 can be positioned within the body vessel 100 using any desired technique and/or approach, including conventional techniques for introducing a catheter into a body vessel and navigating the catheter to a desired point of treatment within the body vessel. As described in more detail below, once a desired first axial location 112 is reached, a user can transition the balloon 22 from an uninflated configuration to an inflated configuration, such as by introducing fluid into the balloon 22 as described above. As a result of this transition, the distal end 84 is released from the guide 60 and radially separates from the balloon 22. Once this separation is achieved, the distal end 84 of the engaging member 80 can engage the inner surface 106 of the vessel 100, such as by contacting the inner surface. If desired, as best illustrated in
It is noted that, while
In this example, guide 260 comprises a raised element 261a disposed on the external surface 258 of the balloon 222. As illustrated, the raised element 261a can be a cutting element that defines an edge 263, such as a raised element used in a cutting and/or scoring balloon known in the art. In this example, the raised element 261a includes structural adaptations that allow it to releasably secure the distal end 284 of the engaging member 280. For example, the raised element 261a includes an axial portion 265 that includes edge 263 and another axial portion 267 that lacks an edge but that includes a channel 269 adapted to receive the distal end 284 of the engaging member 280. In the illustrated example, the raised element 261a also includes an axial portion 271, disposed proximal to the channel 269, that defines a passageway within which a portion of the engaging member 280 is disposed. In this example, the engaging member 280 is fixedly secured within the portion 271 defining the passageway such that it is not axially movable relative to the elongate shaft 212. Any suitable number of additional raised elements, such as raised elements 261b, 261c, 261d in the illustrated example, can also be included, but are considered optional. If included, the additional raised elements can include or not include the structural adaptions for accommodating the guide member, e.g., the channel 269 and axial portion 267 that defines a passageway for receiving a portion of the engaging member 280.
Thus, the catheter 210 includes structural adaptations that make is suitable for use as a cutting and/or scoring catheter and for engaging a vessel from within a lumen defined by the vessel. As described above, the catheter 210 can be used to engage an inner wall of a body vessel by creating contact between the distal end 284 of the engaging member 280 and the inner wall of the body vessel. Alternatively, and similar to the example described above, the catheter can be used to engage an inner wall of a body vessel by using the distal end 284 of the engaging member 280 to puncture the vessel wall. In this example, the engaging member 280 can comprise a cannula suitable for delivering an agent through the cannula or a solid, rod-like structure. Inclusion of a cannula is suitable for catheters according to particular examples with which it is desired to cut and/or score an interior wall of a body vessel and deliver an agent to an interstitial space surrounding the vessel.
In this example, guide 360 comprises a tubular member 361 disposed on the external surface 358 of the balloon. The tubular member 361 defines a passageway 363 and a portion of the engaging member 380 is disposed through the passageway 363. In this example, the engaging member is axially movable within the passageway 363. As such, the engaging member 380 can be used to engage a wall of a body vessel following transition of the balloon 322 from an uninflated configuration to an inflated configuration by distally advancing the distal end 384 of the engaging member 380 through the passageway such that the distal end 384 is exposed, as illustrated in
Also in this example, the elongate shaft 312 defines an engaging member lumen 385 within which the engaging member 380 is disposed. While not illustrated completely in
Similar to the example illustrated in
In contrast to the example illustrated in
Each of
Similar to the example illustrated in
In the illustrated example, the first axial portion 610 of the raised element 561 is disposed on the proximal balloon neck 442 and the second axial portion 612 of the raised element 561 is disposed on the intermediate portion 546 of the balloon 522. As best illustrated in
In the illustrated example, the engaging member 580 is a cannula disposed within the working lumen 590 of the elongate shaft 512. As best illustrated in
A catheter, including those described herein and encompassed by the claims, is useful for engaging the wall of a vessel from within a lumen defined by the vessel. Some examples are useful for puncturing a vessel wall from within a lumen defined by the vessel. The catheters can be used in other locations, too. For example, the catheters can be used during surgical procedures to engage, and, if desired, puncture, a tissue within a cavity of the body. This may be desirable for delivering an agent to the interstitial space beyond the tissue, such as space beyond the abdominal wall for example.
All components of the catheters can be made from any suitable material. Skilled artisans will be able to select appropriate materials for the components of a catheter according to a particular example based on various considerations, including the nature of the body vessel within which the particular catheter is intended to be used. Examples of suitable materials include plastics and other materials used in the manufacture of conventional catheters, and newly-developed materials determined to be suitable for use in components of medical catheters. The inventors have determined that the use of an engaging member formed of a metal material, such as stainless steel, provides advantages for catheters according to particular examples intended to be used for puncturing a body vessel wall from a position within a lumen defined by the vessel and subsequently delivering an agent to the interstitial space surrounding the vessel.
It is noted that structural elements and/or features described herein in connection with one example catheter can be used in combination or in place of structural elements and/or features described in connection with another example catheter. For example, the raised element 561 of the example catheter 510 illustrated in
Non-limiting examples of suitable materials for all components include metals, such as stainless steel, and other metals, and plastics commonly used in medical devices.
In all methods, any catheter according to a suitable example can be used. Also in all methods, the body vessel can comprise any suitable body vessel and the agent can comprise any suitable agent. Thus, the body vessel can comprise any suitable vessel in the body of any animal, including any suitable vessel within the body of a human. The inventors have determined that the methods and catheters are particularly well-suited for delivery of a sclerosing agent to the interstitial space adjacent a renal artery of an animal, such as a human. For these methods, the inventors have determined that ethanol is particularly well-suited for use as a sclerosing agent.
In one particular method, the body vessel comprises a renal artery of an animal and the agent comprises ethanol. This method is suitable for creating renal denervation in the animal, which can be a human.
Examples of other suitable agents for use in a particular method of using a catheter include, but are not limited to, anti-cancer agents, such as paclitaxel; tamoxifen citrate, Taxol® or derivatives thereof, and other anti-cancer chemotherapeutic agents, and immunosuppressive agents, such as cyclosporine and sirolimus. Other examples of bioactives that can be used in the methods and medical devices include, but are not limited to, heparin, covalent heparin or another thrombin inhibitor, hirudin, hirulog, argatroban, D-phenylalanyl-L-poly-L-arginyl chloromethyl ketone, or another antithrombogenic agent, or mixtures thereof; urokinase, streptokinase, a tissue plasminogen activator, or another thrombolytic agent, or mixtures thereof; a fibrinolytic agent; a vasospasm inhibitor; a calcium channel blocker, a nitrate, nitric oxide, a nitric oxide promoter or another vasodilator; an antimicrobial agent or antibiotic; aspirin, ticlopidine, a glycoprotein IIb/IIIa inhibitor or another inhibitor of surface glycoprotein receptors, or another antiplatelet agent; colchicine or another antimitotic, or another microtubule inhibitor, dimethylsulfoxide (DMSO), a retinoid or another antisecretory agent; cytochalasin or another actin inhibitor; or a remodeling inhibitor; deoxyribonucleic acid, an antisense nucleotide or another agent for molecular genetic intervention; methotrexate or another antimetabolite or antiproliferative agent; dexamethasone, dexamethasone sodium phosphate, dexamethasone acetate or another dexamethasone derivative, or another anti-inflammatory steroid or non-steroidal anti-inflammatory agent; tripodal (aPDGF antagonist), angiopeptin (a growth hormone antagonist), angiogenin or other growth factors, or an anti-growth factor antibody, or another growth factor antagonist; dopamine, bromocriptine mesylate, pergolide mesylate or another dopamine agonist; 60Co, 192Ir, 32P, 111In, 90Y, 99mTc or another radiotherapeutic agent; iodine-containing compounds, barium-containing compounds, gold, tantalum, platinum, tungsten or another heavy metal functioning as a radiopaque agent; a peptide, a protein, an enzyme, an extracellular matrix component, a cellular component or another biologic agent; captopril, enalapril or another angiotensin converting enzyme (ACE) inhibitor; ascorbic acid, alpha tocopherol, superoxide dismutase, deferoxamine, a 21-amino steroid (lasaroid) or another free radical scavenger, iron chelator or antioxidant; a 14C-, 3H-, 131I-, 32P- or 36S-radiolabelled form or other radiolabelled form of any of the foregoing; estrogen or another sex hormone; AZT or other antipolymerases; acyclovir, famciclovir, rimantadine hydrochloride, ganciclovir sodium or other antiviral agents; 5-aminolevulinic acid, meta-tetrahydroxyphenylchlorin, hexadecaflouoro zinc phthalocyanine, tetramethyl hematoporphyrin, rhodamine 123 or other photodynamic therapy agents; an IgG2 Kappa antibody against Pseudomonas aeruginosa exotoxin A and reactive with A431 epidermoid carcinoma cells, monoclonal antibody against the noradrenergic enzyme dopamine betahydroxylase conjugated to saporin or other antibody target therapy agents; enalapril or other prodrugs; any endothelium progenitor cell attracting, binding and/or differentiating agents, including suitable chemoattractive agents and suitable polyclonal and monoclonal antibodies; cell migration inhibiting agents, such as smooth muscle cell migration inhibitors, such as Bamimistat, prolylhydrolase inhibitors, Probacol, c-proteinase inhibitors, halofuginone, and other suitable migration inhibitors; and gene therapy agents, and a mixture of any of these.
Those with ordinary skill in the art will appreciate that various modifications and alternatives for the described and illustrated examples can be developed in light of the overall teachings of the disclosure. Accordingly, the particular structures and methods disclosed are intended to be illustrative only and not limiting as to the scope of the invention, which is to be given the full breadth of the claims and any and all equivalents thereof.
Number | Name | Date | Kind |
---|---|---|---|
3173418 | Baran | Mar 1965 | A |
4535757 | Webster, Jr. | Aug 1985 | A |
4571240 | Samson | Feb 1986 | A |
4619261 | Guerriero | Oct 1986 | A |
4637396 | Cook | Jan 1987 | A |
4729763 | Henrie | Mar 1988 | A |
4744366 | Jang | May 1988 | A |
4748982 | Horzewski | Jun 1988 | A |
4762128 | Rosenbluth | Aug 1988 | A |
4777951 | Cribier | Oct 1988 | A |
4877030 | Beck et al. | Oct 1989 | A |
4886061 | Fischell et al. | Dec 1989 | A |
4898575 | Fischell | Feb 1990 | A |
4983167 | Sahota | Jan 1991 | A |
4994033 | Shockey | Feb 1991 | A |
5009659 | Hamilin | Apr 1991 | A |
5019042 | Sahota | May 1991 | A |
5030201 | Palestrant | Jul 1991 | A |
5047040 | Simpson | Sep 1991 | A |
5049132 | Shaffer | Sep 1991 | A |
5057120 | Farcot | Oct 1991 | A |
5078723 | Dance | Jan 1992 | A |
5080660 | Buelna | Jan 1992 | A |
5090958 | Sahota | Feb 1992 | A |
5098381 | Schneider | Mar 1992 | A |
5112305 | Barath | May 1992 | A |
5147377 | Sahota | Sep 1992 | A |
5160321 | Sahota | Nov 1992 | A |
5176637 | Sagae | Jan 1993 | A |
5176693 | Pannek, Jr. | Jan 1993 | A |
5181920 | Mueller | Jan 1993 | A |
5192291 | Pannek, Jr. | Mar 1993 | A |
5196024 | Barath | Mar 1993 | A |
5201706 | Noguchi et al. | Apr 1993 | A |
5209749 | Buelna | May 1993 | A |
5213576 | Abiuso | May 1993 | A |
5224945 | Pannek | Jul 1993 | A |
5224949 | Gomringer | Jul 1993 | A |
5226887 | Farr | Jul 1993 | A |
5232444 | Just | Aug 1993 | A |
5232445 | Banzel | Aug 1993 | A |
5236413 | Feiring | Aug 1993 | A |
5261879 | Brill | Nov 1993 | A |
5273536 | Savas | Dec 1993 | A |
5295962 | Crocker | Mar 1994 | A |
5300085 | Yock | Apr 1994 | A |
5304135 | Shonk | Apr 1994 | A |
5318531 | Leone | Jun 1994 | A |
5320605 | Sahota | Jun 1994 | A |
5320634 | Vigil | Jun 1994 | A |
5330429 | Noguchi et al. | Jul 1994 | A |
5334147 | Johnson | Aug 1994 | A |
5336178 | Kaplan | Aug 1994 | A |
5336234 | Vigil et al. | Aug 1994 | A |
5338298 | McIntyre | Aug 1994 | A |
5342301 | Saab | Aug 1994 | A |
5342305 | Shonk | Aug 1994 | A |
5372601 | Lary | Dec 1994 | A |
5380304 | Parker | Jan 1995 | A |
5395332 | Ressemann | Mar 1995 | A |
5409454 | Fischell | Apr 1995 | A |
5411478 | Stillabower | May 1995 | A |
5415634 | Glynn et al. | May 1995 | A |
5431673 | Summers | Jul 1995 | A |
5441510 | Simpson | Aug 1995 | A |
5447497 | Sogard | Sep 1995 | A |
5450843 | Moll | Sep 1995 | A |
5458568 | Racchini | Oct 1995 | A |
5470315 | Adams | Nov 1995 | A |
5505725 | Samson | Apr 1996 | A |
5522790 | Moll | Jun 1996 | A |
5533968 | Muni | Jul 1996 | A |
5536252 | Imran | Jul 1996 | A |
5547472 | Onishi | Aug 1996 | A |
5556408 | Farhat | Sep 1996 | A |
5558642 | Schweich, Jr. | Sep 1996 | A |
5569184 | Crocker | Oct 1996 | A |
5569277 | Evans | Oct 1996 | A |
5571087 | Ressemann | Nov 1996 | A |
5571089 | Crocker | Nov 1996 | A |
5575771 | Walinsky | Nov 1996 | A |
5601582 | Shelton | Feb 1997 | A |
5603721 | Lau et al. | Feb 1997 | A |
5608628 | Keranen | Mar 1997 | A |
5609574 | Kaplan | Mar 1997 | A |
5611775 | Machold | Mar 1997 | A |
5616149 | Barath | Apr 1997 | A |
5624704 | Darouiche | Apr 1997 | A |
5628746 | Clayman | May 1997 | A |
5645789 | Roucher, Jr. | Jul 1997 | A |
5649909 | Cornelius | Jul 1997 | A |
5669874 | Feiring | Sep 1997 | A |
5685847 | Barry | Nov 1997 | A |
5690642 | Osborne | Nov 1997 | A |
5704913 | Abele | Jan 1998 | A |
5713913 | Lary et al. | Feb 1998 | A |
5720726 | Marcadis | Feb 1998 | A |
5722949 | Sanese | Mar 1998 | A |
5722979 | Kusleika | Mar 1998 | A |
5728063 | Preissman et al. | Mar 1998 | A |
5730733 | Mortier | Mar 1998 | A |
5755685 | Andersen | May 1998 | A |
5766203 | Imran et al. | Jun 1998 | A |
5779698 | Clayman | Jul 1998 | A |
5792106 | Mische | Aug 1998 | A |
5792158 | Lary | Aug 1998 | A |
5797878 | Bleam | Aug 1998 | A |
5797935 | Barath | Aug 1998 | A |
5800392 | Racchini | Sep 1998 | A |
5810867 | Zarbatany | Sep 1998 | A |
5814061 | Osborne | Sep 1998 | A |
5823996 | Sparks | Oct 1998 | A |
5866561 | Ungs | Feb 1999 | A |
5904679 | Clayman | May 1999 | A |
5910144 | Hayashi | Jun 1999 | A |
5921958 | Ressemann | Jul 1999 | A |
5941869 | Patterson | Aug 1999 | A |
6010521 | Lee | Jan 2000 | A |
6030405 | Zarbatany | Feb 2000 | A |
6033380 | Butaric | Mar 2000 | A |
6036689 | Tu | Mar 2000 | A |
6036708 | Sciver | Mar 2000 | A |
6048332 | Duffy | Apr 2000 | A |
6071285 | Lashinski | Jun 2000 | A |
6123718 | Tu | Sep 2000 | A |
6126634 | Bagaoisan | Oct 2000 | A |
6129706 | Janacek | Oct 2000 | A |
6129737 | Hamilton | Oct 2000 | A |
6143016 | Bleam et al. | Nov 2000 | A |
6149641 | Ungs | Nov 2000 | A |
6165187 | Reger | Dec 2000 | A |
6221043 | Fischell | Apr 2001 | B1 |
6231572 | Hart | May 2001 | B1 |
6245040 | Inderbitzen | Jun 2001 | B1 |
6254608 | Solar | Jul 2001 | B1 |
6258099 | Mareiro | Jul 2001 | B1 |
6258108 | Lary | Jul 2001 | B1 |
6280411 | Lennox | Aug 2001 | B1 |
6280413 | Clark et al. | Aug 2001 | B1 |
6280464 | Hayashi | Aug 2001 | B1 |
6283947 | Mirzaee | Sep 2001 | B1 |
6306151 | Lary | Oct 2001 | B1 |
6344028 | Barry | Feb 2002 | B1 |
6355013 | van Muiden | Mar 2002 | B1 |
6355016 | Bagaoisan et al. | Mar 2002 | B1 |
6358266 | Bonutti | Mar 2002 | B1 |
6371961 | Osborne | Apr 2002 | B1 |
6383212 | Durcan | May 2002 | B2 |
6413203 | Sahatjian | Jul 2002 | B1 |
6475187 | Gerberding | Nov 2002 | B1 |
6488653 | Lombardo | Dec 2002 | B1 |
6491662 | Liprie | Dec 2002 | B1 |
6500186 | Lafontaine | Dec 2002 | B2 |
6506202 | Dutta et al. | Jan 2003 | B1 |
6508824 | Flaherty | Jan 2003 | B1 |
6517533 | Swaminathan | Feb 2003 | B1 |
6540734 | Chiu | Apr 2003 | B1 |
6544221 | Kokish | Apr 2003 | B1 |
6544223 | Kokish | Apr 2003 | B1 |
6554841 | Yang | Apr 2003 | B1 |
6589207 | El Nounou | Jul 2003 | B1 |
6616651 | Stevens | Sep 2003 | B1 |
6623452 | Chien | Sep 2003 | B2 |
6626861 | Hart | Sep 2003 | B1 |
6629951 | Laufer et al. | Oct 2003 | B2 |
6629953 | Boyd | Oct 2003 | B1 |
6632231 | Radisch, Jr. | Oct 2003 | B2 |
6659977 | Kastenhofer | Dec 2003 | B2 |
6696121 | Jung, Jr. | Feb 2004 | B2 |
6719774 | Wang | Apr 2004 | B1 |
6730105 | Shiber | May 2004 | B2 |
6733474 | Kusleika | May 2004 | B2 |
6733486 | Lee | May 2004 | B1 |
6746463 | Schwartz | Jun 2004 | B1 |
6747463 | Rynhart | Jun 2004 | B2 |
6808518 | Wellman et al. | Oct 2004 | B2 |
6808531 | Lafontaine | Oct 2004 | B2 |
6837870 | Duchamp | Jan 2005 | B2 |
6855124 | Gonzalez | Feb 2005 | B1 |
6863856 | Mahoney | Mar 2005 | B1 |
6878329 | Blankenship | Apr 2005 | B2 |
6881216 | Di Caprio | Apr 2005 | B2 |
6896842 | Hamilton | May 2005 | B1 |
6923787 | Wang | Aug 2005 | B2 |
6939320 | Lennox | Sep 2005 | B2 |
6942680 | Grayzel | Sep 2005 | B2 |
6960187 | Kastenhofer | Nov 2005 | B2 |
6966889 | Saab | Nov 2005 | B2 |
6989025 | Bergmeier | Jan 2006 | B2 |
7004963 | Wang | Feb 2006 | B2 |
7008438 | O'Brien | Mar 2006 | B2 |
7037291 | Lee | May 2006 | B2 |
7048714 | Richter | May 2006 | B2 |
7066905 | Squire et al. | Jun 2006 | B2 |
7115299 | Kokish | Oct 2006 | B2 |
7118551 | Lee | Oct 2006 | B1 |
7179251 | Palasis | Feb 2007 | B2 |
7179345 | Shklnik | Feb 2007 | B2 |
7186237 | Meyer | Mar 2007 | B2 |
7189215 | Murray, III | Mar 2007 | B2 |
7195611 | Simpson | Mar 2007 | B1 |
7225518 | Eidenschink | Jun 2007 | B2 |
7270673 | Yee | Sep 2007 | B2 |
7273471 | Wang et al. | Sep 2007 | B1 |
7279002 | Shaw | Oct 2007 | B2 |
7291158 | Crow | Nov 2007 | B2 |
7294124 | Eidenschink | Nov 2007 | B2 |
7303572 | Melsheimer | Dec 2007 | B2 |
7306616 | Eidenschink et al. | Dec 2007 | B2 |
7314364 | Mahoney | Jan 2008 | B2 |
7338463 | Vigil | Mar 2008 | B2 |
7351214 | Burgermeister | Apr 2008 | B2 |
7351238 | Lee | Apr 2008 | B2 |
7354419 | Davies, Jr. | Apr 2008 | B2 |
7396358 | Appling et al. | Jul 2008 | B2 |
7413558 | Kelley et al. | Aug 2008 | B2 |
7556642 | Trotta | Jul 2009 | B2 |
7591830 | Rutter | Sep 2009 | B2 |
7611484 | Wellman et al. | Nov 2009 | B2 |
7625353 | Grandt | Dec 2009 | B2 |
7628769 | Grandt | Dec 2009 | B2 |
7632242 | Griffin et al. | Dec 2009 | B2 |
7645272 | Chang et al. | Jan 2010 | B2 |
7654997 | Makower et al. | Feb 2010 | B2 |
7658723 | Von Oepen et al. | Feb 2010 | B2 |
7682335 | Pepper et al. | Mar 2010 | B2 |
7691080 | Seward et al. | Apr 2010 | B2 |
7691082 | Shippy, III et al. | Apr 2010 | B2 |
7727226 | Chang et al. | Jun 2010 | B2 |
7762984 | Kumoyama et al. | Jul 2010 | B2 |
7771409 | Chang et al. | Aug 2010 | B2 |
7803150 | Chang et al. | Sep 2010 | B2 |
7879053 | Trinidad | Feb 2011 | B2 |
7909797 | Kennedy, II et al. | Mar 2011 | B2 |
7976557 | Kunis | Jul 2011 | B2 |
7993302 | Herbert et al. | Aug 2011 | B2 |
7993358 | O'Brien | Aug 2011 | B2 |
8043259 | Radisch, Jr. et al. | Oct 2011 | B2 |
8090433 | Makower et al. | Jan 2012 | B2 |
8142422 | Makower et al. | Mar 2012 | B2 |
8150520 | Demarais et al. | Apr 2012 | B2 |
8182446 | Schaeffer et al. | May 2012 | B2 |
8192675 | Burton et al. | Jun 2012 | B2 |
8323307 | Hardert | Dec 2012 | B2 |
8348890 | Gerrans | Jan 2013 | B2 |
8399443 | Seward | Mar 2013 | B2 |
8388642 | Muni et al. | May 2013 | B2 |
8454637 | Aggerholm et al. | Jun 2013 | B2 |
8740843 | Eaton et al. | Jun 2014 | B2 |
8764705 | Hennessey | Jul 2014 | B2 |
8808236 | Orr | Aug 2014 | B2 |
8906049 | Chambers | Dec 2014 | B2 |
8911399 | Boatman | Dec 2014 | B2 |
9211394 | Leffel | Dec 2015 | B2 |
20010041859 | Vigil | Nov 2001 | A1 |
20010051810 | Dubrul | Dec 2001 | A1 |
20020002349 | Flaherty et al. | Jan 2002 | A1 |
20020010489 | Grayzel | Jan 2002 | A1 |
20020032406 | Kusleika | Mar 2002 | A1 |
20020042593 | Mickley | Apr 2002 | A1 |
20020062133 | Gilson et al. | May 2002 | A1 |
20020115982 | Barbut | Aug 2002 | A1 |
20020120250 | Altman | Aug 2002 | A1 |
20020183720 | Hill et al. | Dec 2002 | A1 |
20030028212 | Saab | Feb 2003 | A1 |
20030032851 | Apple | Feb 2003 | A1 |
20030032936 | Lederman | Feb 2003 | A1 |
20030033001 | Igaki | Feb 2003 | A1 |
20030040754 | Mitchell | Feb 2003 | A1 |
20030040770 | Radisch | Feb 2003 | A1 |
20030055444 | Evans et al. | Mar 2003 | A1 |
20030055445 | Evans et al. | Mar 2003 | A1 |
20030114868 | Fischell | Jun 2003 | A1 |
20030114877 | Gellman | Jun 2003 | A1 |
20030144677 | Lary | Jul 2003 | A1 |
20030153870 | Meyer | Aug 2003 | A1 |
20030163148 | Wang | Aug 2003 | A1 |
20030216792 | Levin et al. | Nov 2003 | A1 |
20030229370 | Miller | Dec 2003 | A1 |
20040054351 | Deniega | Mar 2004 | A1 |
20040064093 | Hektner | Apr 2004 | A1 |
20040073297 | Rohde | Apr 2004 | A1 |
20040092870 | Squire et al. | May 2004 | A1 |
20040111108 | Farnan | Jun 2004 | A1 |
20040122457 | Weber | Jun 2004 | A1 |
20040122465 | McMurtry | Jun 2004 | A1 |
20040127920 | Radisch | Jul 2004 | A1 |
20040133223 | Weber | Jul 2004 | A1 |
20040143287 | Konstantino | Jul 2004 | A1 |
20040172121 | Eidenschink | Sep 2004 | A1 |
20040181252 | Boyle | Sep 2004 | A1 |
20040193196 | Appling | Sep 2004 | A1 |
20040199191 | Schwartz | Oct 2004 | A1 |
20040230178 | Wu | Nov 2004 | A1 |
20040243156 | Wu et al. | Dec 2004 | A1 |
20040243158 | Konstantino | Dec 2004 | A1 |
20040260239 | Kusleika | Dec 2004 | A1 |
20050021070 | Feld | Jan 2005 | A1 |
20050021071 | Konstantino | Jan 2005 | A1 |
20050027246 | Dion | Feb 2005 | A1 |
20050033334 | Santra | Feb 2005 | A1 |
20050038383 | Kelley | Feb 2005 | A1 |
20050080478 | Barongan | Apr 2005 | A1 |
20050090845 | Boyd | Apr 2005 | A1 |
20050090846 | Pedersen | Apr 2005 | A1 |
20050102020 | Grayzel et al. | May 2005 | A1 |
20050137616 | Vigil | Jun 2005 | A1 |
20050240148 | Cheves | Oct 2005 | A1 |
20050288629 | Kunis | Dec 2005 | A1 |
20050288632 | William | Dec 2005 | A1 |
20060015133 | Grayzel | Jan 2006 | A1 |
20060015134 | Trinidad | Jan 2006 | A1 |
20060020256 | Bell | Jan 2006 | A1 |
20060111736 | Kelley | May 2006 | A1 |
20060129178 | Reifart | Jun 2006 | A1 |
20060149192 | Deniega | Jul 2006 | A1 |
20060149308 | Melsheimer | Jul 2006 | A1 |
20060173487 | Uflacker | Aug 2006 | A1 |
20060178685 | Melsheimer | Aug 2006 | A1 |
20060184112 | Horn et al. | Aug 2006 | A1 |
20060200110 | Lentz | Sep 2006 | A1 |
20060224115 | William | Oct 2006 | A1 |
20060258987 | Lentz | Nov 2006 | A1 |
20060287665 | Burton | Dec 2006 | A1 |
20070016278 | Shippy, III et al. | Jan 2007 | A1 |
20070073329 | Hardert | Mar 2007 | A1 |
20070106215 | Olsen | May 2007 | A1 |
20070112370 | Andrews | May 2007 | A1 |
20070118076 | Lim | May 2007 | A1 |
20070129751 | Muni et al. | Jun 2007 | A1 |
20070135830 | Schaeffer | Jun 2007 | A1 |
20070142771 | Durcan | Jun 2007 | A1 |
20070244431 | Limon | Oct 2007 | A1 |
20080065012 | Hebert et al. | Mar 2008 | A1 |
20080077164 | Murphy | Mar 2008 | A1 |
20080077165 | Murphy | Mar 2008 | A1 |
20080228139 | Melsheimer et al. | Sep 2008 | A1 |
20080255507 | Mushtaha | Oct 2008 | A1 |
20080288041 | Holman | Nov 2008 | A1 |
20080300610 | Chambers | Dec 2008 | A1 |
20090005754 | Soetermans | Jan 2009 | A1 |
20090018502 | Reifart | Jan 2009 | A1 |
20090171283 | Schaeffer et al. | Jul 2009 | A1 |
20090192537 | O'Brien | Jul 2009 | A1 |
20090234283 | Burton et al. | Sep 2009 | A1 |
20090254064 | Boatman | Oct 2009 | A1 |
20090299450 | Johnson et al. | Dec 2009 | A1 |
20090306582 | Granada et al. | Dec 2009 | A1 |
20100010470 | Bates | Jan 2010 | A1 |
20100030144 | Brunner et al. | Feb 2010 | A1 |
20100042046 | Chang et al. | Feb 2010 | A1 |
20100069900 | Shirley | Mar 2010 | A1 |
20100094259 | Makower et al. | Apr 2010 | A1 |
20100114066 | Makower et al. | May 2010 | A1 |
20100174308 | Chang et al. | Jul 2010 | A1 |
20100185146 | Ramzipoor | Jul 2010 | A1 |
20100198191 | Clifford et al. | Aug 2010 | A1 |
20100274171 | Kelley | Oct 2010 | A1 |
20100274188 | Chang et al. | Oct 2010 | A1 |
20100298862 | Chang et al. | Nov 2010 | A1 |
20110054443 | Weber | Mar 2011 | A1 |
20110060276 | Schaeffer et al. | Mar 2011 | A1 |
20110137245 | Schaeffer | Jun 2011 | A1 |
20110160740 | Makower et al. | Jun 2011 | A1 |
20110182912 | Evans et al. | Jul 2011 | A1 |
20110196190 | Farnan et al. | Aug 2011 | A1 |
20120143054 | Eaton | Jun 2012 | A1 |
20120184983 | Chang et al. | Jul 2012 | A1 |
20120226230 | Gerrans | Sep 2012 | A1 |
20120271277 | Fischell et al. | Oct 2012 | A1 |
20120316436 | Lentz et al. | Dec 2012 | A1 |
20120316589 | Schaeffer | Dec 2012 | A1 |
20130041399 | Hardert | Feb 2013 | A1 |
20130053822 | Fischell et al. | Feb 2013 | A1 |
20130103026 | Kleshinski | Apr 2013 | A1 |
20130178790 | Tekulve | Jul 2013 | A1 |
20130237909 | Orr | Sep 2013 | A1 |
20140031792 | Schaeffer et al. | Jan 2014 | A1 |
20140088624 | Burton et al. | Mar 2014 | A1 |
20140100592 | Burton et al. | Apr 2014 | A1 |
20140155927 | Burton | Jun 2014 | A1 |
20150174371 | Schaeffer et al. | Jun 2015 | A1 |
20150342631 | Wilson | Dec 2015 | A1 |
Number | Date | Country |
---|---|---|
102600546 | Jul 2012 | CN |
4225553 | May 1994 | DE |
0835673 | Apr 1998 | EP |
083567 | Sep 1999 | EP |
1230944 | Aug 2002 | EP |
WO9619257 | Jun 1996 | WO |
WO1999004851 | Feb 1999 | WO |
WO1999048545 | Sep 1999 | WO |
WO2001060443 | Aug 2001 | WO |
WO2004060460 | Jul 2004 | WO |
WO2006020180 | Feb 2006 | WO |
WO2006074256 | Jul 2006 | WO |
WO2006114783 | Nov 2006 | WO |
WO2006136964 | Dec 2006 | WO |
WO2008045242 | Apr 2008 | WO |
WO2009033026 | Mar 2009 | WO |
WO2009036118 | Mar 2009 | WO |
WO2009036135 | Mar 2009 | WO |
WO2009114425 | Sep 2009 | WO |
WO2010024871 | Mar 2010 | WO |
WO2010065030 | Jun 2010 | WO |
WO2010120620 | Oct 2010 | WO |
WO2011082074 | Jul 2011 | WO |
WO2012161875 | Nov 2012 | WO |
WO2013059735 | Apr 2013 | WO |
WO2013063331 | May 2013 | WO |
Entry |
---|
Mafeld, et al., “Renal Denervation for Treatment-Resistant Hypertension,” Therapeutic Advances in Cardiovascular Disease, 2012 6(6), 245-258, retrieved from http://www.medscape.com/viewarticle/775538 on Mar. 10, 2015. |
Boston Scientific, Flextome Cutting Balloon Dilation Device, screenshot of product information taken from Boston Scientific company website (http://www.bostonscientific.com/Device.bsci?page=HCP_Overview&navRelId=1000.1003&method=DevDetailHCP&id=10004791&pageDisclaimer=Disclaimer.ProductPage) visited on Sep. 19, 2012. |
European Patent Office, Extended European Search Report, Patent App. No. 13178419.1, dated Nov. 27, 2013, pp. 2-8. |
Kuhn F.A. et al., “Balloon catheter sinusotomy: One-year follow-up—Outcomes and role in functional endoscopic sinus surgery,” Otolaryngology-Head and Neck Surgery, 2008, vol. 139, S27-S37. |
Taghi, A.S. et al., “Balloon Sinuplasty: balloon-catheter dilation of paranasal sinus ostia for chronic rhinosinusitis,” Expert Reviews Medical Devices, 2009, vol. 6(4), pp. 377-382. |
Bolger W.E., et al., “Safety and outcomes of balloon catheter sinusotomy: A multicenter 24-week analysis in 115 patients,” Otolaryngology-Head and Neck Surgery, 2007, vol. 137, pp. 10-20. |
Dorado PTA Dilation Catheter Brochure, Bard Peripheral Vascular, 2011, 4 pgs. |
Number | Date | Country | |
---|---|---|---|
20150157832 A1 | Jun 2015 | US |
Number | Date | Country | |
---|---|---|---|
61914697 | Dec 2013 | US |